Akorn Company Profile (NASDAQ:AKRX)

About Akorn

Akorn logoAkorn Inc. (Akorn), together with its wholly owned subsidiaries, is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as animal and over-the-counter (OTC) consumer health products. The Company specializes in sterile and non-sterile dosage forms, including ophthalmics, injectables, oral liquids, otics, topicals, inhalants and nasal sprays. The Company operates in two segments: Prescription Pharmaceuticals, which is engaged in the sale of branded and generic prescription pharmaceuticals, and Consumer Health, which is engaged in the sale of branded and private label consumer and animal health products. The Company operates pharmaceutical manufacturing facilities in Decatur, Illinois; Somerset, New Jersey; Amityville, New York, and Paonta Sahib, Himachal Pradesh, India, as well as a central distribution warehouse in Gurnee, Illinois, and an additional warehousing facility in Amityville, New York.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: AKRX
  • CUSIP: 00972810
Key Metrics:
  • Previous Close: $27.78
  • 50 Day Moving Average: $28.31
  • 200 Day Moving Average: $28.11
  • 52-Week Range: $17.57 - $39.46
  • Trailing P/E Ratio: 18.71
  • Foreward P/E Ratio: 12.38
  • P/E Growth: 1.57
  • Market Cap: $3.50B
  • Outstanding Shares: 126,029,000
  • Beta: 1.08
Profitability:
  • Net Margins: 17.00%
  • Return on Equity: 32.83%
  • Return on Assets: 10.90%
Debt:
  • Debt-to-Equity Ratio: 1.04%
  • Current Ratio: 4.28%
  • Quick Ratio: 2.93%
Additional Links:
Companies Related to Akorn:

Analyst Ratings

Consensus Ratings for Akorn (NASDAQ:AKRX) (?)
Ratings Breakdown: 5 Hold Ratings, 10 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $34.86 (25.68% upside)

Analysts' Ratings History for Akorn (NASDAQ:AKRX)
Show:
DateFirmActionRatingPrice TargetDetails
9/15/2016Piper Jaffray Cos.UpgradeNeutral -> Overweight$33.00 -> $34.00View Rating Details
8/29/2016Jefferies GroupReiterated RatingBuy$35.00View Rating Details
8/5/2016WallachBeth CapitalBoost Price TargetBuy$39.00 -> $40.00View Rating Details
8/5/2016JPMorgan Chase & Co.Set Price TargetBuy$45.00View Rating Details
8/5/2016Deutsche Bank AGDowngradeBuy -> Hold$33.00 -> $33.00View Rating Details
8/2/2016Raymond James Financial Inc.DowngradeOutperform -> Market PerformView Rating Details
8/2/2016Citigroup Inc.DowngradeMarket Perform$33.80 -> $34.00View Rating Details
7/28/2016RBC Capital MarketsReiterated RatingOutperform$37.00View Rating Details
7/18/2016Royal Bank Of CanadaReiterated RatingBuyView Rating Details
5/26/2016Leerink SwannReiterated RatingHoldView Rating Details
5/17/2016GuggenheimReiterated RatingBuy$40.00View Rating Details
3/22/2016Craig HallumReiterated RatingBuyView Rating Details
3/23/2016SusquehannaLower Price TargetNeutral$32.00 -> $30.00View Rating Details
3/23/2016William BlairReiterated RatingOutperform$58.00 -> $36.00View Rating Details
3/22/2016S&P Equity ResearchLower Price Target$25.98 -> $21.97View Rating Details
3/21/2016NomuraLower Price TargetBuy$46.00 -> $42.00View Rating Details
9/9/2015JMP SecuritiesInitiated CoverageMarket PerformView Rating Details
3/27/2015Avondale PartnersInitiated CoverageOutperform$56.00View Rating Details
2/27/2015Needham & Company LLCDowngradeBuy -> HoldView Rating Details
2/4/2015Sterne Agee CRTInitiated CoverageBuy$52.00View Rating Details
11/13/2014CRT CapitalUpgradeFair Value -> Buy$46.00View Rating Details
(Data available from 9/29/2014 forward)

Earnings

Earnings History for Akorn (NASDAQ:AKRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2016        
8/4/2016Q216$0.55$0.58$272.99 million$280.70 millionViewListenView Earnings Details
5/16/2016Q116$0.43$0.54$268.00 millionViewListenView Earnings Details
2/26/2015Q414$0.45$0.50$218.87 million$227.80 millionViewListenView Earnings Details
11/6/2014Q314$0.25$0.27$155.20 million$132.70 millionViewListenView Earnings Details
8/5/2014Q214$0.20$0.25$145.16 million$150.70 millionViewListenView Earnings Details
5/6/2014Q114$0.15$0.16$91.44 million$90.60 millionViewN/AView Earnings Details
3/3/2014Q413$0.14$0.14$83.37 million$85.00 millionViewN/AView Earnings Details
11/5/2013Q313$0.14$0.15$80.43 million$81.90 millionViewN/AView Earnings Details
8/6/2013Q2 2013$0.13$0.14$75.06 million$77.00 millionViewN/AView Earnings Details
5/7/2013Q1 2013$0.14$0.13$74.07 million$73.90 millionViewN/AView Earnings Details
2/26/2013Q4 2012$0.12$0.13$69.42 million$71.50 millionViewN/AView Earnings Details
11/6/2012Q312$0.13$0.12$69.59 million$69.60 millionViewN/AView Earnings Details
8/7/2012$0.12$0.12ViewN/AView Earnings Details
5/8/2012$0.12$0.13ViewN/AView Earnings Details
3/6/2012$0.09$0.11ViewN/AView Earnings Details
11/1/2011$0.06$0.13ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Akorn (NASDAQ:AKRX)
Current Year EPS Consensus Estimate: $2.11 EPS
Next Year EPS Consensus Estimate: $2.24 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.50$0.50$0.50
Q2 20162$0.47$0.53$0.50
Q3 20162$0.53$0.53$0.53
Q4 20162$0.52$0.55$0.54
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Akorn (NASDAQ:AKRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Akorn (NASDAQ:AKRX)
Insider Ownership Percentage: 30.10%
Institutional Ownership Percentage: 73.62%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/15/2016Kenneth AbramowitzDirectorSell2,691$30.44$81,914.04View SEC Filing  
6/14/2016Joseph BonaccorsiSVPSell6,500$29.84$193,960.00View SEC Filing  
6/10/2016Kenneth AbramowitzDirectorSell14,675$30.16$442,598.00View SEC Filing  
6/9/2016Bruce KutinskyCOOSell142,000$31.12$4,419,040.00View SEC Filing  
6/7/2016Ronald M JohnsonDirectorSell7,542$31.49$237,497.58View SEC Filing  
6/6/2016Kenneth AbramowitzDirectorSell10,900$31.37$341,933.00View SEC Filing  
6/3/2016Joseph BonaccorsiSVPSell90,250$31.23$2,818,507.50View SEC Filing  
6/2/2016Alan D WeinsteinDirectorSell50,000$30.93$1,546,500.00View SEC Filing  
4/21/2015Mark M SilverbergVPSell29,000$55.00$1,595,000.00View SEC Filing  
3/10/2015John N KapoorDirectorBuy19,000$44.26$840,940.00View SEC Filing  
3/3/2015Rajat RaiCEOBuy5,000$47.70$238,500.00View SEC Filing  
2/18/2015Joseph BonaccorsiInsiderSell40,827$47.33$1,932,341.91View SEC Filing  
2/10/2015Ronald M JohnsonDirectorSell17,173$46.44$797,514.12View SEC Filing  
1/26/2015Rajat RaiCEOSell873,985$41.89$36,611,231.65View SEC Filing  
1/12/2015Mark M SilverbergVPSell38,602$41.00$1,582,682.00View SEC Filing  
1/9/2015Ronald M JohnsonDirectorSell17,173$40.46$694,819.58View SEC Filing  
1/2/2015Ronald M JohnsonDirectorSell14,300$36.12$516,516.00View SEC Filing  
1/2/2015Timothy A DickCFOSell30,150$36.03$1,086,304.50View SEC Filing  
12/15/2014Brian TambiDirectorSell1,200$41.86$50,232.00View SEC Filing  
12/12/2014Adrienne L GravesDirectorSell9,557$41.09$392,697.13View SEC Filing  
12/11/2014John N KapoorDirectorSell50,000$41.19$2,059,500.00View SEC Filing  
12/9/2014John R SabatVPSell43,173$40.53$1,749,801.69View SEC Filing  
12/1/2014Timothy A DickCFOSell30,875$39.23$1,211,226.25View SEC Filing  
11/3/2014Timothy A DickCFOSell122,222$44.08$5,387,545.76View SEC Filing  
10/1/2014Timothy A DickCFOSell122,222$35.24$4,307,103.28View SEC Filing  
9/12/2014Brian TambiDirectorSell13,800$38.00$524,400.00View SEC Filing  
9/11/2014Joseph BonaccorsiInsiderSell116,800$37.89$4,425,552.00View SEC Filing  
9/8/2014Kenneth AbramowitzDirectorSell4,500$36.54$164,430.00View SEC Filing  
9/8/2014Rajat RaiCEOSell147,000$36.78$5,406,660.00View SEC Filing  
9/8/2014Timothy A DickCFOSell45,000$37.61$1,692,450.00View SEC Filing  
9/4/2014Alan D WeinsteinDirectorSell5,000$38.49$192,450.00View SEC Filing  
8/26/2014John N KapoorDirectorSell50,000$38.99$1,949,500.00View SEC Filing  
8/7/2014Rajat RaiCEOSell903,659$33.62$30,381,015.58View SEC Filing  
6/13/2014Brian TambiDirectorBuy1,000$27.62$27,620.00View SEC Filing  
5/16/2014Rajat RaiCEOBuy5,000$26.76$133,800.00View SEC Filing  
5/14/2014Kenneth AbramowitzDirectorSell2,557$26.79$68,502.03View SEC Filing  
12/9/2013Alan WeinsteinDirectorSell20,000$25.52$510,400.00View SEC Filing  
12/3/2013Kenneth AbramowitzDirectorSell5,000$25.35$126,750.00View SEC Filing  
12/12/2012Alan D WeinsteinDirectorBuy30,500$13.67$416,935.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Akorn (NASDAQ:AKRX)
DateHeadline
News IconHC Stocks Impression! Akorn, Inc. (AKRX), DENTSPLY SIRONA Inc (NASDAQ:XRAY) - share market updates (press release) (NASDAQ:AKRX)
sharemarketupdates.com - September 26 at 3:23 PM
News IconAnalysts Valuations For Two Stocks: Skechers USA Inc (NYSE:SKX), Akorn, Inc. (NASDAQ:AKRX) - The Voice Registrar (NASDAQ:AKRX)
voiceregistrar.com - September 26 at 9:44 AM
nasdaq.com logoPeek Under The Hood: XPH Has 25% Upside (NASDAQ:AKRX)
www.nasdaq.com - September 23 at 3:50 PM
News Icon142,000 Shares of Akorn, Inc. (AKRX) Stock are sold by Bruce ... - DailyQuint (NASDAQ:AKRX)
dailyquint.com - September 23 at 8:14 AM
News IconAnalysis under Consideration: Akorn, Inc. (NASDAQ:AKRX) - Theriponadvance.com (NASDAQ:AKRX)
theriponadvance.com - September 23 at 8:14 AM
News IconAnalysts Valuations For Two Stocks: Akorn, Inc. (NASDAQ:AKRX), Robert Half International Inc. (NYSE:RHI) - The Voice Registrar (NASDAQ:AKRX)
voiceregistrar.com - September 22 at 3:23 PM
News Icon10900 Shares of Stock are sold by Insider Selling: Akorn, Inc. (AKRX) Director - DailyQuint (NASDAQ:AKRX)
dailyquint.com - September 21 at 9:55 AM
News IconShares With Gains Over the Past Half Year: Akorn, Inc. (NASDAQ ... - Post News (NASDAQ:AKRX)
www.kentuckypostnews.com - September 19 at 8:11 AM
News IconAnalysts Valuations For Two Stocks: Brocade Communications Systems, Inc. (NASDAQ:BRCD), Akorn, Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:AKRX)
voiceregistrar.com - September 16 at 3:25 PM
News IconFund Move to Note: As Akorn INC (AKRX) Valuation Rose, Holder ... - Chester News (NASDAQ:AKRX)
www.chesterindependent.com - September 16 at 3:25 PM
investors.com logoWall St shares climb after weaker sales quash rate hike (NASDAQ:AKRX)
www.proactiveinvestors.com - September 15 at 12:18 PM
finance.yahoo.com logoAkorn upgraded by Piper Jaffray (NASDAQ:AKRX)
finance.yahoo.com - September 15 at 12:18 PM
thestreet.com logoAkorn (AKRX) Stock Gains, Rating Raised at Piper Jaffray (NASDAQ:AKRX)
www.thestreet.com - September 15 at 12:18 PM
News IconInvestor Scope: Checking in on Shares of Akorn, Inc. (NASDAQ:AKRX) - Post News (NASDAQ:AKRX)
www.kentuckypostnews.com - September 14 at 8:59 AM
News IconWhat are Analysts Expecting for Akorn, Inc. (NASDAQ:AKRX) Earnings? - Frisco Fastball (NASDAQ:AKRX)
friscofastball.com - September 14 at 8:59 AM
News IconStock Up Over the Past Five Trading Sessions: Akorn, Inc. (NASDAQ:AKRX) - Post News (NASDAQ:AKRX)
www.kentuckypostnews.com - September 13 at 8:14 AM
News IconHC Stocks Updates= Seattle Genetics, Inc. (SGEN), Akorn, Inc. (NASDAQ:AKRX) - share market updates (press release) (NASDAQ:AKRX)
sharemarketupdates.com - September 12 at 3:24 PM
News IconAnalysts Valuations For Two Stocks: Akorn, Inc. (NASDAQ:AKRX), Foot Locker, Inc. (NYSE:FL) - The Voice Registrar (NASDAQ:AKRX)
voiceregistrar.com - September 12 at 8:12 AM
News IconNext Weeks Broker Price Targets For Akorn, Inc. (NASDAQ:AKRX ... - National Daily Press (NASDAQ:AKRX)
www.nationaldailypress.com - September 11 at 8:10 AM
News IconShares Lower Over the Past Quarter: Akorn, Inc. (NASDAQ:AKRX) - Post News (NASDAQ:AKRX)
www.kentuckypostnews.com - September 10 at 3:22 PM
News IconMarket Review: Watching Session Activity of Akorn, Inc. (NASDAQ:AKRX) Shares - Post News (NASDAQ:AKRX)
www.kentuckypostnews.com - September 9 at 3:23 PM
marketrealist.com logoConsumer Healthcare Segment Expects Revenue of $2.6 Billion in 2016 (NASDAQ:AKRX)
marketrealist.com - September 9 at 3:23 PM
News IconInstitutional Investors Have Decreased Positions in Akorn, Inc. (NASDAQ:AKRX) - National Daily Press (NASDAQ:AKRX)
www.nationaldailypress.com - September 9 at 8:13 AM
News IconAkorn, Inc. (NASDAQ:AKRX): What is the Sell-side Making of this Stock? - National Daily Press (NASDAQ:AKRX)
www.nationaldailypress.com - September 9 at 8:13 AM
News IconPlacing Akorn, Inc. (NASDAQ:AKRX) Shares Under the Microscope - National Daily Press (NASDAQ:AKRX)
www.nationaldailypress.com - September 9 at 8:13 AM
News IconStock Sliding Down Over the Last Month: Akorn, Inc. (NASDAQ:AKRX) - Post News (NASDAQ:AKRX)
www.kentuckypostnews.com - September 8 at 3:24 PM
News IconHistory of Akorn, Inc. (NASDAQ:AKRX) stock price after earnings - The Independent Republic (NASDAQ:AKRX)
theindependentrepublic.com - September 8 at 3:24 PM
News IconStock Seeing Accelerated Sales Growth Quarter over Quarter: Akorn, Inc. (NASDAQ:AKRX) - Post News (NASDAQ:AKRX)
www.kentuckypostnews.com - September 6 at 8:32 PM
News IconStock Struggling for the Quarter: Akorn, Inc. (NASDAQ:AKRX) - Post News (NASDAQ:AKRX)
www.kentuckypostnews.com - September 4 at 8:11 AM
News IconStock Buzzer - Akorn, Inc.'s (AKRX) - Hot Stocks Point (NASDAQ:AKRX)
www.hotstockspoint.com - September 2 at 3:26 PM
News IconAnalysts Valuations For Two Stocks: Xylem Inc (NYSE:XYL), Akorn ... - The Voice Registrar (NASDAQ:AKRX)
voiceregistrar.com - September 2 at 3:26 PM
News IconStock in Review: Taking a Closer Look at Akorn, Inc. (NASDAQ:AKRX) Shares - Post News (NASDAQ:AKRX)
www.kentuckypostnews.com - September 2 at 8:02 AM
News IconShares Slipping Lower Over the Past Month: Akorn, Inc. (NASDAQ:AKRX) - Post News (NASDAQ:AKRX)
www.kentuckypostnews.com - September 1 at 11:51 AM
capitalcube.com logoETF’s with exposure to Akorn, Inc. : September 1, 2016 (NASDAQ:AKRX)
www.capitalcube.com - September 1 at 11:51 AM
News IconAkorn, Inc. (NASDAQ:AKRX) Analyst Opinion - The Independent Republic (NASDAQ:AKRX)
theindependentrepublic.com - August 31 at 3:24 PM
News IconAnalysts Valuations For Two Stocks: Akorn, Inc. (NASDAQ:AKRX), BankUnited (NYSE:BKU) - The Voice Registrar (NASDAQ:AKRX)
voiceregistrar.com - August 31 at 8:11 AM
seekingalpha.com logoBuy Akorn: Unjustly Punished By Mylan Controversy - Seeking Alpha (NASDAQ:AKRX)
seekingalpha.com - August 30 at 3:24 PM
News IconAnalysts Valuations For Two Stocks: Akorn, Inc. (NASDAQ:AKRX), United Rentals, Inc. (NYSE:URI) - The Voice Registrar (NASDAQ:AKRX)
voiceregistrar.com - August 30 at 3:24 PM
seekingalpha.com logoBuy Akorn: Unjustly Punished By Mylan Controversy (NASDAQ:AKRX)
seekingalpha.com - August 30 at 12:19 PM
marketrealist.com logoAkorn in 2016: What Are Its Key Risk Factors? (NASDAQ:AKRX)
marketrealist.com - August 30 at 12:19 PM
marketrealist.com logoAkorn’s Robust Research and Development Pipeline: A Growth Driver (NASDAQ:AKRX)
marketrealist.com - August 29 at 9:04 PM
finance.yahoo.com logoYour Complete Guide to the Generic Drug Industry (NASDAQ:AKRX)
finance.yahoo.com - August 29 at 9:04 PM
News IconAkorn, Inc. (NASDAQ:AKRX) topped earnings-per-share estimates ... - The Independent Republic (NASDAQ:AKRX)
theindependentrepublic.com - August 29 at 4:02 PM
marketrealist.com logoAkorn’s 2016 Valuation Multiples Compared to Peers (NASDAQ:AKRX)
marketrealist.com - August 29 at 4:02 PM
marketrealist.com logoAnalyst Recommendations for Akorn in 2016 (NASDAQ:AKRX)
marketrealist.com - August 29 at 4:02 PM
seekingalpha.com logoAkorn - Time To Consider Again At Levels In The Mid-Twenties (NASDAQ:AKRX)
seekingalpha.com - August 27 at 8:11 AM
News IconStocks Roundup: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Akorn, Inc. (NASDAQ:AKRX) - NYSE Journal (press release) (NASDAQ:AKRX)
stockznews.com - August 26 at 11:33 AM
News IconInvestor's Watch List: TG Therapeutics Inc (NASDAQ:TGTX), Akorn, Inc. (NASDAQ:AKRX) - NYSE Journal (press release) (NASDAQ:AKRX)
stockznews.com - August 25 at 8:49 PM
forbes.com logoRelative Strength Alert For Akorn (NASDAQ:AKRX)
www.forbes.com - August 25 at 5:58 PM
News IconMovers to Watch – Pernix Therapeutics Holdings (NASDAQ:PTX ... - Money News (press release) (NASDAQ:AKRX)
www.newsismoney.com - August 25 at 3:25 PM

Social

Akorn (NASDAQ:AKRX) Chart for Thursday, September, 29, 2016


Last Updated on 9/29/2016 by MarketBeat.com Staff